![John L. Mee](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Actieve functies van John L. Mee
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Cognigenics, Inc.
![]() Cognigenics, Inc. Miscellaneous Commercial ServicesCommercial Services Cognigenics, Inc. is a company founded in 2019 that specializes in genetic neuroengineering using patent-pending CRISPR technology to target and modulate neural circuits responsible for mental health disorders such as anxiety, depression, ADHD, and cognitive impairment. The company is based in Eagle, ID. Cognigenics is revolutionizing the treatment of mental health conditions through their innovative technology. The company was founded by John L. Mee, Dean Radin, and Barry J. Linder, with John L. Mee serving as CEO since incorporation. | President | 13-01-2024 | - |
Oprichter | - | - | |
Algemeen Directeur | - | 13-01-2024 |
Loopbaan van John L. Mee
Statistieken
Internationaal
Verenigde Staten | 2 |
Operationeel
Chief Executive Officer | 1 |
Founder | 1 |
President | 1 |
Sectoraal
Commercial Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 1 |
---|---|
Cognigenics, Inc.
![]() Cognigenics, Inc. Miscellaneous Commercial ServicesCommercial Services Cognigenics, Inc. is a company founded in 2019 that specializes in genetic neuroengineering using patent-pending CRISPR technology to target and modulate neural circuits responsible for mental health disorders such as anxiety, depression, ADHD, and cognitive impairment. The company is based in Eagle, ID. Cognigenics is revolutionizing the treatment of mental health conditions through their innovative technology. The company was founded by John L. Mee, Dean Radin, and Barry J. Linder, with John L. Mee serving as CEO since incorporation. | Commercial Services |
- Beurs
- Insiders
- John L. Mee
- Ervaring